Health Care: Drugs

Celldex Therapeutics Inc. (CLDX: NASDAQ)

$12.69 0.29 | 2.34%
05/17/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 11.20M 9.26M 46.79M 15.18M
Cost of Sales 9.39M 6.85M 9.37M 5.81M
Gross Operating Profit 1.81M 2.41M 37.42M 9.37M
Selling, General, and Administrative Expenses 10.02M 9.24M 10.43M 17.12M
Research & Development 47.40M 32.44M 27.65M 26.17M
Operating Income before D & A (EBITDA) -55.60M -39.27M -658.00K -33.92M
Depreciation & Amortization 2.48M 4.18M 5.85M 3.53M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 530.00K 446.00K 5.31M 852.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -57.55M -43.00M -1.20M -36.60M
Interest Expense 1.58M 1.80M 1.34M 452.00K
Pre-Tax Income -59.12M -44.80M -2.53M -37.05M
Income Taxes 0.00 0.00 0.00 -529.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -59.12M 0.00 0.00 -36.52M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -59.12M 0.00 0.00 -36.52M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -59.12M -44.80M -2.53M -36.52M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -59.12M 0.00 0.00 -36.52M
Preferred Dividends
Net Income Available To Common -59.12M 0.00 0.00 -36.52M
Basic EPS from Continuing Ops. -1.02 -1.13 -0.08 -1.84
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.02 -1.13 -0.08 -1.84
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.02 -1.13 -0.08 -1.84
Basic Normalized Net Income/Share -1.02 n.a. n.a. -1.84
EPS fr Continuing Ops. -1.02 -1.13 -0.08 -1.84
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.02 -1.13 -0.08 -1.84
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.02 -1.13 -0.08 -1.84
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -1.02 n.a. n.a. -1.84
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with CLDX

View All

Latest CLDX Headlines from TheStreet

More Financial News for CLDX

Press Releases for CLDX

See All Press Releases

Partner Headlines for CLDX

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter